Going from a medium-dose inhaled corticosteroid to a biologic for asthma led to significant decreases in exacerbations, ...

ICS are commonly used in bronchiectasis patients, despite guidelines advising against it unless specific conditions are present. The study found ICS users with elevated eosinophils had fewer ...

Ireland’s national body for ICT professionals, as announced the appointment of Tom O’Sullivan FICS as chief executive officer. The appointment marks a significant moment for ICS as it enters the final ...